Network Pharmacology and In Vivo Validation Reveal Berberine-Mediated Regulation of the Liver–Brain Inflammatory Axis in MCD-Induced Steatohepatitis
Network pharmacology and molecular docking were used to predict BBR targets and pathways, followed by in vivo validation in a methionine- and choline-deficient diet-induced mouse model, suggesting that BBR alleviates MCD-induced steatohepatitis through multi-target regulation of hepatic metabolic dysfunction, immune re...